Matinas Biopharma Holdings Inc. Common Stock (MTNB)

About MTNB

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Website

www.matinasbiopharma.com/

Fundamentals

Market cap

$1.72M

P/E (trailing)

—

P/E (forward)

—

EPS (trailing)

$-1.62

Dividend yield

—

Beta

2.07

Avg. volume

—

Matinas Biopharma Holdings Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• MTNB

  Matinas Biopharma Holdings Inc. Common Stock

  $0.1966

  ▼ 1.70%
  Market cap $1.72MP/E —
  $0.178$2.14
• BDRX

  Biodexa Pharmaceuticals plc American Depositary Shs

  $0.8351

  ▼ 7.21%
  Market cap $1.10MP/E —
  $0.8303$59.4
• OGEN

  Oragenics Inc. Common Stock

  $0.5296

  ▼ 0.08%
  Market cap $2.45MP/E 0.56
  $0.4801$1.45
• CDT

  CDT Equity Inc. Common Stock

  $1.69

  ▼ 10.37%
  Market cap $2.54MP/E —
  $1.62$2,928
• ARTL

  Artelo Biosciences Inc. Common Stock

  $0.6619

  ▲ 0.14%
  Market cap $2.62MP/E —
  $0.52$28.14
• SBFM

  Sunshine Biopharma Inc. Common Stock

  $1.16

  ▼ 8.66%
  Market cap $2.97MP/E —
  $1.01$24.3
• SXTP

  60 Degrees Pharmaceuticals Inc. Common Stock

  $1.03

  ▼ 2.83%
  Market cap $3.28MP/E —
  $1.01$8.62

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Which stocks are gapping on Thursday?
  ChartMill · 8/20/2026
• 12 Health Care Stocks Moving In Thursday's Intraday Session
  Benzinga · 8/20/2026
• Stay updated with the stocks that are on the move in today's pre-market session.
  ChartMill · 8/20/2026
• 12 Health Care Stocks Moving In Thursday's Pre-Market Session
  Benzinga · 8/20/2026
• Why Webull Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
  Benzinga · 8/20/2026
• What's going on in today's after hours session
  ChartMill · 8/19/2026
• 12 Health Care Stocks Moving In Wednesday's After-Market Session
  Benzinga · 8/19/2026
• Matinas BioPharma Has Received A Notice Of Allowance For A U.S. Patent Titled "ENCOCHLEATED ANTIFUNGAL COMPOUNDS FOR CENTRAL NERVOUS SYSTEM DELIVERY AND TREATMENT OF CRYPTOCOCCUS INFECTIONS".
  Benzinga · 8/19/2026

• Adam K. Stern · July 10, 2026 · J

  141.5K @ $0.35
• Adam K. Stern · July 10, 2026 · Grant

  344.7K @ $0.35
• Adam K. Stern · July 10, 2026 · X

  344.7K @ $0.35
• Adam K. Stern · July 10, 2026 · Grant

  630.3K @ $0.35
• Adam K. Stern · July 10, 2026 · X

  630.3K @ $0.35
• Sanitam Partners LLC · June 10, 2026 · J

  4.80M @ $0.6446
• Sanitam Partners LLC · June 10, 2026 · J

  1.4K @ $0.586

Institutional Ownership

March 31, 2026

Total shares held

334.7K

Total value held

$167.5K

Institutional holders

26